Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Intercure Ltd (INCR)

Intercure Ltd (INCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 118,490
  • Shares Outstanding, K 45,573
  • Annual Sales, $ 119,720 K
  • Annual Income, $ 13,360 K
  • 60-Month Beta 1.73
  • Price/Sales 1.08
  • Price/Cash Flow 6.42
  • Price/Book 0.80
Trade INCR with:

Options Overview Details

View History
  • Implied Volatility 111.22% ( +3.71%)
  • Historical Volatility 74.94%
  • IV Percentile 36%
  • IV Rank 17.64%
  • IV High 604.87% on 12/06/23
  • IV Low 5.51% on 05/15/23
  • Put/Call Vol Ratio 1.00
  • Today's Volume 2
  • Volume Avg (30-Day) 66
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 870
  • Open Int (30-Day) 1,027

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/17
See More
  • Average Estimate 0.52
  • Number of Estimates 2
  • High Estimate 0.53
  • Low Estimate 0.51
  • Prior Year 0.61
  • Growth Rate Est. (year over year) -14.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.21 +20.81%
on 03/27/24
2.92 -8.56%
on 04/03/24
+0.13 (+5.12%)
since 03/22/24
3-Month
1.18 +126.27%
on 01/31/24
2.92 -8.56%
on 04/03/24
+1.41 (+111.90%)
since 01/24/24
52-Week
0.99 +169.70%
on 11/02/23
2.92 -8.56%
on 04/03/24
+0.50 (+23.04%)
since 04/24/23

Most Recent Stories

More News
Organigram and InterCure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), ( “Organigram”) a leading Canadian licensed producer of cannabis and Canndoc Ltd. (“Canndoc”), a subsidiary of InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U)...

INCR.TO : N/A (N/A)
OGI : 1.9300 (-1.03%)
OGI.TO : 2.66 (-0.75%)
INCR-U.TO : 1.53 (+4.08%)
INCR : 2.67 (+2.69%)
InterCure to Release its Q2 2022 Results and Hold a Conference Call

Conference call scheduled for Tuesday, August 16, 2022, at 8:30am ET...

INCR.TO : N/A (N/A)
INCR-U.TO : 1.53 (+4.08%)
INCR : 2.67 (+2.69%)
InterCure Reports Record Preliminary 2022 Second Quarter Revenue – More Than Double YoY and 9% QoQ Growth

Estimated revenue reaches CAD$36 million 1(a record NIS 95 million) Anticipates continued increases in EBITDA Revenue growth expected to...

INCR.TO : N/A (N/A)
INCR : 2.67 (+2.69%)
INCR-U.TO : 1.53 (+4.08%)
InterCure and Cookies Launch Flagship Retail Location in Vienna, Austria

NEW YORK and TORONTO and HERZLIYA, Israel, June 21, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) ("InterCure" or the...

INCR.TO : N/A (N/A)
INCR-U.TO : 1.53 (+4.08%)
INCR : 2.67 (+2.69%)
InterCure and Cookies Successfully Launch Flagship Pharmacy in Be'er Sheva, Israel

Cookies Be'er Sheva is the largest medical cannabis dedicated pharmacy in Israel...

INCR.TO : N/A (N/A)
INCR-U.TO : 1.53 (+4.08%)
INCR : 2.67 (+2.69%)
InterCure Begins 2022 with Record Breaking First Quarter Financial Results

Record revenue of $341 million in the first quarter of 2022 Adjusted EBITDA2 increased almost 110% year-over-year to $8 million Net income of $6...

INCR.TO : N/A (N/A)
INCR : 2.67 (+2.69%)
INCR-U.TO : 1.53 (+4.08%)
InterCure to Release its Q1 2022 Results and Hold a Conference Call

Conference call scheduled for Tuesday, May 17, 2022, at 8:00am ET...

INCR.TO : N/A (N/A)
INCR-U.TO : 1.53 (+4.08%)
INCR : 2.67 (+2.69%)
InterCure to Participate in Upcoming Investor Conferences in May 2022

NEW YORK, TORONTO, and HERZLIYA, Israel, May 09, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba...

INCR.TO : N/A (N/A)
INCR-U.TO : 1.53 (+4.08%)
INCR : 2.67 (+2.69%)
InterCure to Participate in A.G.P.’s Spring Consumer Cannabis Conference

NEW YORK and TORONTO and HERZLIYA, Israel, May 03, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)...

INCR.TO : N/A (N/A)
INCR-U.TO : 1.53 (+4.08%)
INCR : 2.67 (+2.69%)
InterCure Reports Record Breaking Q4 and 2021 Results – Exceeded Preliminary Results

Another record year with continued industry leading growth and profitability supported by focused strategy and execution Revenue growth expected to...

INCR.TO : N/A (N/A)
INCR : 2.67 (+2.69%)
INCR-U.TO : 1.53 (+4.08%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

InterCure is a cannabis company. It is a licensed cannabis producer which offer good manufacturing practices certified and pharmaceutical-grade medical cannabis products. InterCure is based in NEW YORK.

See More

Key Turning Points

3rd Resistance Point 3.00
2nd Resistance Point 2.89
1st Resistance Point 2.78
Last Price 2.67
1st Support Level 2.56
2nd Support Level 2.45
3rd Support Level 2.34

See More

52-Week High 2.92
Last Price 2.67
Fibonacci 61.8% 2.18
Fibonacci 50% 1.95
Fibonacci 38.2% 1.73
52-Week Low 0.99

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar